Cooperative Agreement W81XWH1020158

Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $575,356 Project Grant to The Trustees of Columbia University in the City of New York (Health Sciences Division) on August 8, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award funds development of an accessible, sample-to-answer reverse transcription polymerase chain reaction (RT-PCR) diagnostic platform for rapid hepatitis C virus (HCV)...

Federal Project Grant Award Summary Case Western Reserve University received a $354,570 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 7, 2025, with a completion date of June 30, 2030. The university will develop an innovative point-of-care diagnostic tool called CAMOchip for detecting HIV/Hepatitis B Virus (HBV) co-infection. The technology employs a microchip utilizing...

Lo Biosciences, Inc., a minority-owned biotechnology company based in Rockville, MD, received a $1,989,316 Project Grant from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) awarded on September 30, 2025. The grant supports the development of a novel remote blood separation device designed to enable at-home plasma collection for Human Immunodeficiency Virus Type 1 (HIV-1) testing. This two-year project, with an ultimate...

The National Heart, Lung, and Blood Institute (NHLBI) awarded a $297,587 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to General Fluidics Corporation to validate the performance of the AXESS system, a novel point-of-need clinical chemistry and hematology platform. The goal is to demonstrate equivalence between the AXESS system's results and those obtained from standard venous blood testing for a basic metabolic panel and complete blood count, using matched capillary and...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $537,619 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Central Florida Board of Trustees. The grant, awarded on March 1, 2025, will support the development of a single biosensor platform for the simultaneous detection of HIV, hepatitis B, and hepatitis C viruses, particularly in resource-limited settings. The project aims to integrate the university's recently...

Federal Grant Award Summary New York University School of Medicine received a $841,719 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective April 1, 2026 through March 31, 2031. This research initiative will develop and validate low-cost, rapid antibody-based tests to complement HIV polymerase chain reaction (PCR) viral load testing for treatment monitoring. The project...

Federal Grant Award Summary Rutgers The State University of New Jersey (RBHS-School of Nursing) received a $272,133 Project Grant from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded June 18, 2025, with completion targeted for May 31, 2027. The award supports the development of a low-cost, instrument-free rapid antigen test for diagnosing active Hepatitis C Virus (HCV) infection. The research aims to...

Federal Grant Award Summary Aptus Biosciences LLC, a minority-owned small business located in Gainesville, Florida, received a $1.0M Project Grant award from the Centers for Disease Control and Prevention (CDC) under the Prevention of Disease, Disability, and Death by Infectious Diseases program (CFDA 93.084). The award, obligated on September 30, 2025, with a completion date of September 29, 2026, supports the development of a rapid, affordable aptamer-based diagnostic test for Hepatitis C...

Federal Project Grant Award Summary New York University School of Medicine received a $1.72M Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded April 20, 2026, with completion targeted for March 31, 2033. This multicenter clinical trial—the HOPE Heart Study—will evaluate the safety and efficacy of heart transplantation from HIV-positive donors (HIV D+) to HIV-positive recipients...

Federal Grant Award Summary The University of Connecticut Health Center received a $647,533 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025, through July 31, 2030. The award funds development of a rapid, affordable, and sensitive HIV viral load testing platform utilizing CRISPR cascade signal amplification technology. The project will investigate the...